A new global public-private partnership using artificial intelligence (AI) to accelerate drug discovery is launching with UCL as one of the lead academic partners. The five-year project has a budget of more than €60 million, funded by the European Union and industry partners through the Innovative Health Initiative (IHI). The LIGAND-AI consortium brings together 18 partners across nine countries to generate large open, high-quality datasets of how molecules (ligands) bind to proteins, and use